Optimum Investment Advisors Coh Bar, Inc. Transaction History

Optimum Investment Advisors

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$0.17 - $0.34 $21,114 - $42,228	-124,200 Reduced 50.26%	122,910 $23,000
Q1 2022 Apr 08, 2022	SELL	$0.25 - $0.43 $9,750 - $16,770	-39,000 Reduced 13.63%	247,110 $78,000
Q4 2021 Mar 17, 2022	SELL	$0.34 - $1.0 $3,400 - $10,000	-10,000 Reduced 3.38%	286,110 $100,000
Q3 2021 Oct 22, 2021	SELL	$0.96 - $1.62 $6,240 - $10,530	-6,500 Reduced 2.15%	296,110 $284,000
Q2 2021 Aug 02, 2021	BUY	$1.09 - $1.49 $10,900 - $14,900	10,000 Added 3.42%	302,610 $424,000
Q4 2019 Jan 22, 2020	BUY	$1.2 - $2.34 $4,800 - $9,360	4,000 Added 1.39%	292,610 $468,000
Q3 2019 Oct 17, 2019	BUY	$1.3 - $1.76 $416 - $563	320 Added 0.11%	288,610 $375,000
Q1 2019 May 03, 2019	BUY	$2.95 - $4.16 $29,500 - $41,600	10,000 Added 3.59%	288,290 $940,000
Q2 2018 Oct 05, 2018	BUY	$4.44 - $10.4 $4,440 - $10,400	1,000 Added 0.36%	278,290 $1.82 Million
Q1 2018 May 09, 2018	BUY	$4.85 - $6.92 $28,857 - $41,174	5,950 Added 2.19%	277,290 $1.44 Million
Q4 2017 Jan 16, 2018	BUY	$4.91 - $5.5 $1.33 Million - $1.49 Million	271,340	271,340 $1.35 Million

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Optimum Investment Advisors with notifications on news.